 |
BioWorld-Insight-2003-02-03
Stock Winners and Losers For The Week
As War Looms, Sector Could Have 'Biggest Product Year Ever'
With 20 drugs approved last year, a somewhat brightened market picture in the final quarter of 2002 and Phase III data due in the months ahead, analysts are finding cause for optimism even as the rumblings of war grow louder.